Low LH in CAH: The Mechanism
Low LH in congenital adrenal hyperplasia is NOT directly caused by high 17-hydroxyprogesterone itself, but rather by the elevated androgens (testosterone and androstenedione) that result from the shunting of steroid precursors toward sex hormone biosynthesis when the 21-hydroxylase enzyme is deficient.
Understanding the Pathophysiology
In CAH due to 21-hydroxylase deficiency, the fundamental problem is impaired cortisol synthesis. The 21-hydroxylase enzyme normally converts 17-OHP to 11-deoxycortisol (a cortisol precursor) and progesterone to deoxycorticosterone (an aldosterone precursor) 1.
The Steroid Shunting Mechanism
When this enzyme is deficient:
- Cortisol synthesis is blocked, leading to low cortisol levels
- ACTH secretion increases in response to low cortisol (loss of negative feedback)
- Elevated ACTH drives adrenal hyperplasia and stimulates the adrenal cortex 1, 2
- Cortisol precursors accumulate, including 17-OHP (which becomes markedly elevated—often >10,000 ng/dL in classic CAH) 1
- These accumulated precursors are diverted to sex hormone biosynthesis, producing excessive androgens (testosterone, androstenedione) 1
Why LH Becomes Low
The elevated androgens suppress the hypothalamic-pituitary-gonadal axis through negative feedback:
- High testosterone and other androgens suppress GnRH pulsatility from the hypothalamus
- This results in suppressed LH and FSH secretion (hypogonadotropic state)
- The case report 2 demonstrates this perfectly: a 31-year-old male with 21-OHD had "low levels of both LH and FSH but high levels of free testosterone"—classic evidence that the androgens, not 17-OHP itself, suppress gonadotropins
Evidence from Treatment Response
When cortisol treatment is given, the mechanism reverses 3:
- Cortisol replacement suppresses ACTH
- This reduces adrenal androgen production
- Withdrawal of cortisol for 3 days resulted in a significant decrease in the mean serum FSH/LH ratio and a rise in serum testosterone—demonstrating that it's the androgens controlling gonadotropin levels, not 17-OHP directly
Clinical Implications
Key Diagnostic Pattern
In untreated or poorly controlled CAH, expect:
- Markedly elevated 17-OHP (>10,000 ng/dL in classic forms) 1
- Elevated androgens (testosterone, androstenedione)
- Low or inappropriately normal LH/FSH despite high androgens
- High ACTH with low cortisol 2
The 17-OHP Role
17-OHP is a diagnostic marker for 21-hydroxylase deficiency, not the direct cause of LH suppression. It accumulates because it cannot be converted forward in the cortisol synthesis pathway, but it's the downstream androgens that suppress the gonadotropin axis 1, 4.
Treatment Restores Normal Axis
Proper glucocorticoid replacement 1:
- Suppresses excessive ACTH
- Reduces 17-OHP levels (though complete normalization causes overtreatment)
- Decreases androgen production
- Allows recovery of normal LH/FSH secretion
Common Pitfall
Do not confuse the elevated 17-OHP with the cause of LH suppression. While 17-OHP levels are dramatically elevated and serve as the primary diagnostic marker for 21-OHD, the gonadotropin suppression occurs via the classic negative feedback mechanism from elevated sex steroids (particularly testosterone), which are produced when accumulated steroid precursors are shunted toward androgen synthesis 1, 2, 3.